Using R and OpenBUGS for Evaluating the Causal Effect of Dynamic Treatment Regimes
|
|
- Sharyl Garrison
- 5 years ago
- Views:
Transcription
1 Using R and OpenBUGS for Evaluating the Causal Effect of Dynamic Treatment Regimes Daniel Scharfstein and Chenguang Wang June 9, 2010 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 1/42
2 Outline 1 Acute Lung Injury and ARMA Trial 2 Bayesian Causal Inference 3 R and BUGS 4 Application Results of the ARMA Trial 5 Concluding Remarks C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 2/42
3 Acute Lung Injury (ALI) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 3/42
4 Acute Lung Injury (ALI) ALI is a condition characterized by acute onset of Shortness of breath Rapid breathing rate Low oxygen levels Abnormal chest x-ray C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 3/42
5 Acute Lung Injury (ALI) ALI is a condition characterized by acute onset of Shortness of breath Rapid breathing rate Low oxygen levels Abnormal chest x-ray Adult respiratory distress syndrome (ARDS) is a subset of ALI with more severe hypoxemia. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 3/42
6 Acute Lung Injury (ALI) ALI is a condition characterized by acute onset of Shortness of breath Rapid breathing rate Low oxygen levels Abnormal chest x-ray Adult respiratory distress syndrome (ARDS) is a subset of ALI with more severe hypoxemia. ALI can be a direct injury to the lung (e.g. pneumonia) or indirect lung injury (e.g. pancreatitis). C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 3/42
7 Acute Lung Injury (ALI) ALI is a condition characterized by acute onset of Shortness of breath Rapid breathing rate Low oxygen levels Abnormal chest x-ray Adult respiratory distress syndrome (ARDS) is a subset of ALI with more severe hypoxemia. ALI can be a direct injury to the lung (e.g. pneumonia) or indirect lung injury (e.g. pancreatitis). Several (meta-analysis) studies have found that mortality rate for ALI patients is about 40%. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 3/42
8 Acute Lung Injury (ALI) ALI is a condition characterized by acute onset of Shortness of breath Rapid breathing rate Low oxygen levels Abnormal chest x-ray Adult respiratory distress syndrome (ARDS) is a subset of ALI with more severe hypoxemia. ALI can be a direct injury to the lung (e.g. pneumonia) or indirect lung injury (e.g. pancreatitis). Several (meta-analysis) studies have found that mortality rate for ALI patients is about 40%. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 3/42
9 Mechanical Ventilation for ALI C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 4/42
10 Mechanical Ventilation for ALI ALI patients often require mechanical ventilation in an intensive care unit (ICU) to help them breathe. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 4/42
11 Mechanical Ventilation for ALI ALI patients often require mechanical ventilation in an intensive care unit (ICU) to help them breathe. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 4/42
12 Mechanical Ventilation - Key Terminology C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 5/42
13 Mechanical Ventilation - Key Terminology C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 5/42
14 Mechanical Ventilation - Key Terminology Positive end-expiratory pressure (PEEP): the alveolar pressure at the beginning of the breath C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 5/42
15 Mechanical Ventilation - Key Terminology Positive end-expiratory pressure (PEEP): the alveolar pressure at the beginning of the breath Plateau pressure (PP): pressure experienced by lung at end of each breath C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 5/42
16 Mechanical Ventilation - Key Terminology Positive end-expiratory pressure (PEEP): the alveolar pressure at the beginning of the breath Plateau pressure (PP): pressure experienced by lung at end of each breath Tidal volume (VT): Size of breath given to patient from ventilator (set by doctor) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 5/42
17 Mechanical Ventilation - Key Terminology Positive end-expiratory pressure (PEEP): the alveolar pressure at the beginning of the breath Plateau pressure (PP): pressure experienced by lung at end of each breath Tidal volume (VT): Size of breath given to patient from ventilator (set by doctor) Lung compliance (LC): stiffness of lungs (increases with severity of ALI) VT LC = PP PEEP C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 5/42
18 ARMA Lower Tidal Volume Trial C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 6/42
19 ARMA Lower Tidal Volume Trial The ARMA study was a randomized, controlled multi-center 2 x 2 factorial study conducted by the National Heart, Blood and Lung Institute (NHBLI) ARDS Clinical Network C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 6/42
20 ARMA Lower Tidal Volume Trial The ARMA study was a randomized, controlled multi-center 2 x 2 factorial study conducted by the National Heart, Blood and Lung Institute (NHBLI) ARDS Clinical Network The study consisted of a drug treatment (Ketoconazole vs. placebo) and a ventilation strategy (6ml/kg tidal volume vs. 12ml/kg tidal volume) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 6/42
21 ARMA Lower Tidal Volume Trial The ARMA study was a randomized, controlled multi-center 2 x 2 factorial study conducted by the National Heart, Blood and Lung Institute (NHBLI) ARDS Clinical Network The study consisted of a drug treatment (Ketoconazole vs. placebo) and a ventilation strategy (6ml/kg tidal volume vs. 12ml/kg tidal volume) A total of 432 patients were randomized to lower tidal volume ventilation arm. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 6/42
22 Lower Tidal Volume Ventilation (LTVV) Set initial tidal volume to 6 ml/kg predicted body weight (PBW) Decrease VT to 5 or 4 ml/kg, if necessary, to get PP < 30 If VT < 6 ml/kg and PP < 25, increase VT 1 ml/kg (not > 6 ml/kg) If VT = 6 ml/kg, PP < 30, and severe dyspnea, increase VT to 7 or 8 ml/kg (if PP remains < 30) If blood very acidotic, OK for VT and PP to be > 6ml/kg and 30, respectively C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 7/42
23 Controversy: Non-adherence C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 8/42
24 Controversy: Non-adherence ARMA ventilation strategy comparison result: 40% vs. 31% in-hospital mortality (p=0.007) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 8/42
25 Controversy: Non-adherence ARMA ventilation strategy comparison result: 40% vs. 31% in-hospital mortality (p=0.007) Some argued that the LTVV is not optimal because the adherence to the LTVV protocol was not perfect. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 8/42
26 Controversy: Non-adherence ARMA ventilation strategy comparison result: 40% vs. 31% in-hospital mortality (p=0.007) Some argued that the LTVV is not optimal because the adherence to the LTVV protocol was not perfect. Physicians deviated from the LTVV protocol when they thought specific aspects of the protocol were detrimental to their patients. For example, when patients appeared to be very dyspneic (short of breath) while receiving 6 ml/kg PBW, some physicians raised tidal volume above 6 ml/kg PBW in an attempt to alleviate the dyspnea. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 8/42
27 Controversy: Non-adherence ARMA ventilation strategy comparison result: 40% vs. 31% in-hospital mortality (p=0.007) Some argued that the LTVV is not optimal because the adherence to the LTVV protocol was not perfect. Physicians deviated from the LTVV protocol when they thought specific aspects of the protocol were detrimental to their patients. For example, when patients appeared to be very dyspneic (short of breath) while receiving 6 ml/kg PBW, some physicians raised tidal volume above 6 ml/kg PBW in an attempt to alleviate the dyspnea. The deviations from the LTVV protocol may have improved the outcome of some patients. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 8/42
28 Adherence Specification C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 9/42
29 Adherence Specification In the ARMA trial, VT selection procedure was not recorded C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 9/42
30 Adherence Specification In the ARMA trial, VT selection procedure was not recorded A set of specifications were developed, using VT, PP, PH etc., to determine if LTVV was followed C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 9/42
31 Adherence Specification In the ARMA trial, VT selection procedure was not recorded A set of specifications were developed, using VT, PP, PH etc., to determine if LTVV was followed Plateau pressure > 30 tidal volume 4.5 or ph < 7.2 Tidal volume 3 tidal volume 8.5 ph < 7.2 and set respiratory rate < tidal volume 8.5 (ph < 7.2 and set respiratory rate 35) or (plateau pressure 30 and severe dyspnea) tidal volume 6.5 Plateau pressure 30 or ph < < tidal volume < Plateau pressure tidal volume 4.5 Plateau pressure 25 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 9/42
32 Adherence Specification In the ARMA trial, VT selection procedure was not recorded A set of specifications were developed, using VT, PP, PH etc., to determine if LTVV was followed Plateau pressure > 30 tidal volume 4.5 or ph < 7.2 Tidal volume 3 tidal volume 8.5 ph < 7.2 and set respiratory rate < tidal volume 8.5 (ph < 7.2 and set respiratory rate 35) or (plateau pressure 30 and severe dyspnea) tidal volume 6.5 Plateau pressure 30 or ph < < tidal volume < Plateau pressure tidal volume 4.5 Plateau pressure 25 Adherence: (1 or 2) AND (3 or 4 or 5 or 6 or 7) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 9/42
33 Adherence Specification In the ARMA trial, VT selection procedure was not recorded A set of specifications were developed, using VT, PP, PH etc., to determine if LTVV was followed Plateau pressure > 30 tidal volume 4.5 or ph < 7.2 Tidal volume 3 tidal volume 8.5 ph < 7.2 and set respiratory rate < tidal volume 8.5 (ph < 7.2 and set respiratory rate 35) or (plateau pressure 30 and severe dyspnea) tidal volume 6.5 Plateau pressure 30 or ph < < tidal volume < Plateau pressure tidal volume 4.5 Plateau pressure 25 Adherence: (1 or 2) AND (3 or 4 or 5 or 6 or 7) Over 28% observed ventilation days deviated from the LTVV. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 9/42
34 Goal We seek to draw inference about the distribution of survival that would have resulted had all patients in the LTVV arm of the ARDSNet study strictly adhered to the LTVV protocol. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 10/42
35 Statistical Challenges C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
36 Statistical Challenges Time-Dependent Dynamic Treatment Regime C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
37 Statistical Challenges Time-Dependent Dynamic Treatment Regime In a non-dynamic (static) treatment regime the treatment level and type are specified before treatment is started and not changed with a patient s response C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
38 Statistical Challenges Time-Dependent Dynamic Treatment Regime In a non-dynamic (static) treatment regime the treatment level and type are specified before treatment is started and not changed with a patient s response LTVV is individually tailored treatment: the treatment is provided to patients only when it is needed and the level of treatment is adjusted based on time-dependent measurements of the patient s need for treatment C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
39 Statistical Challenges Time-Dependent Dynamic Treatment Regime In a non-dynamic (static) treatment regime the treatment level and type are specified before treatment is started and not changed with a patient s response LTVV is individually tailored treatment: the treatment is provided to patients only when it is needed and the level of treatment is adjusted based on time-dependent measurements of the patient s need for treatment The challenge is to isolate the effect of LTVV from the confounding effect of the time-dependent confounders C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
40 Statistical Challenges Time-Dependent Dynamic Treatment Regime In a non-dynamic (static) treatment regime the treatment level and type are specified before treatment is started and not changed with a patient s response LTVV is individually tailored treatment: the treatment is provided to patients only when it is needed and the level of treatment is adjusted based on time-dependent measurements of the patient s need for treatment The challenge is to isolate the effect of LTVV from the confounding effect of the time-dependent confounders G-computation C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
41 Statistical Challenges Time-Dependent Dynamic Treatment Regime In a non-dynamic (static) treatment regime the treatment level and type are specified before treatment is started and not changed with a patient s response LTVV is individually tailored treatment: the treatment is provided to patients only when it is needed and the level of treatment is adjusted based on time-dependent measurements of the patient s need for treatment The challenge is to isolate the effect of LTVV from the confounding effect of the time-dependent confounders G-computation Missing Data C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
42 Statistical Challenges Time-Dependent Dynamic Treatment Regime In a non-dynamic (static) treatment regime the treatment level and type are specified before treatment is started and not changed with a patient s response LTVV is individually tailored treatment: the treatment is provided to patients only when it is needed and the level of treatment is adjusted based on time-dependent measurements of the patient s need for treatment The challenge is to isolate the effect of LTVV from the confounding effect of the time-dependent confounders G-computation Missing Data Missing of ventilator parameters was non-negligible(e.g. PP 11.6%, arterial ph 28.7%) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
43 Statistical Challenges Time-Dependent Dynamic Treatment Regime In a non-dynamic (static) treatment regime the treatment level and type are specified before treatment is started and not changed with a patient s response LTVV is individually tailored treatment: the treatment is provided to patients only when it is needed and the level of treatment is adjusted based on time-dependent measurements of the patient s need for treatment The challenge is to isolate the effect of LTVV from the confounding effect of the time-dependent confounders G-computation Missing Data Missing of ventilator parameters was non-negligible(e.g. PP 11.6%, arterial ph 28.7%) Fully parametric model assuming missing at random C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 11/42
44 Outline 1 Acute Lung Injury and ARMA Trial 2 Bayesian Causal Inference 3 R and BUGS 4 Application Results of the ARMA Trial 5 Concluding Remarks C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 12/42
45 Data Structure For an individual patient, the observed data is as follows: Var Definition and Description Day 1... Day 28 S t Survival HSP t Hospitalization ICU t ICU indicator VNT t Ventilator indicator LC t * Lung compliance PE t Positive end-expiratory pressure PH t ph PD t PP t PEEP t SO t Oxygen saturation SR t Respiratory set rate DS t Severe dyspnea OF t * Organ failure AP Baseline Apache score * OF is observed at baseline. LC = VT/PD C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 13/42
46 Notation C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
47 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
48 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) Let L t = {L 0,L 1,...,L t } C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
49 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) Let L t = {L 0,L 1,...,L t } Let R t = I(VNT t = 1) be the at-risk indicator on day t C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
50 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) Let L t = {L 0,L 1,...,L t } Let R t = I(VNT t = 1) be the at-risk indicator on day t Let H t = {HSP t,icu t,vnt t,lc t } and U t = {PE t,ph t,pd t,so t,sr t,ds t,of t } C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
51 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) Let L t = {L 0,L 1,...,L t } Let R t = I(VNT t = 1) be the at-risk indicator on day t Let H t = {HSP t,icu t,vnt t,lc t } and U t = {PE t,ph t,pd t,so t,sr t,ds t,of t } Let A t = I((VT t,pp t,ph t,sr t,ds t ) S) where S is the set of combinations defined in the adherence table C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
52 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) Let L t = {L 0,L 1,...,L t } Let R t = I(VNT t = 1) be the at-risk indicator on day t Let H t = {HSP t,icu t,vnt t,lc t } and U t = {PE t,ph t,pd t,so t,sr t,ds t,of t } Let A t = I((VT t,pp t,ph t,sr t,ds t ) S) where S is the set of combinations defined in the adherence table Let A t = 1 if S t = 0 or R t = 0 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
53 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) Let L t = {L 0,L 1,...,L t } Let R t = I(VNT t = 1) be the at-risk indicator on day t Let H t = {HSP t,icu t,vnt t,lc t } and U t = {PE t,ph t,pd t,so t,sr t,ds t,of t } Let A t = I((VT t,pp t,ph t,sr t,ds t ) S) where S is the set of combinations defined in the adherence table Let A t = 1 if S t = 0 or R t = 0 Let S t be the counterfactual survival. That is, the survival that would have been observed had a patient been treated according to the LTVV protocol C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
54 Notation Let L t = {S t,hsp t ICU t,vnt t,lc t,pe t,ph t,pd t,so t,sr t,ds t,of t } be the scheduled observed data on day t (t = 0,...,28) Let L t = {L 0,L 1,...,L t } Let R t = I(VNT t = 1) be the at-risk indicator on day t Let H t = {HSP t,icu t,vnt t,lc t } and U t = {PE t,ph t,pd t,so t,sr t,ds t,of t } Let A t = I((VT t,pp t,ph t,sr t,ds t ) S) where S is the set of combinations defined in the adherence table Let A t = 1 if S t = 0 or R t = 0 Let S t be the counterfactual survival. That is, the survival that would have been observed had a patient been treated according to the LTVV protocol re: The goal is to estimate P(S t = 1) for all t C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 14/42
55 Assumption I C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 15/42
56 Assumption I Stochastic Consistency: P[S t = 1 S t 1 = 1,Āt 1 = 1, H t 1 = h t 1,Ūt 1 = ū t 1 ] = P[S t = 1 S t 1 = 1,Āt 1 = 1, H t 1 = h t 1,Ūt 1 = ū t 1 ] This assumption implies that the potential survival outcome under the LTVV protocol is uniquely determined. That is, if the physician followed the protocol, the treatment for an individual is unique and therefore her potential survival outcome is unique. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 15/42
57 Assumption II Evaluable Outcome P[A t = 1 S t = 1,Āt 1 = 1, H t = h t,ūt 1 = ū t 1 ] > 0 This assumes that when a group of patients have been treated with the LTVV protocol until day t, at least some of them will continue to be treated with adherence to the protocol on day t+1. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 16/42
58 Assumption III Sequential Randomization A t (S k : k = 2,...,28) Ā t 1,S t = 1,R t = 1, H t,ūt 1 This assumption will hold if H t and Ūt 1 includes all risk factors, other than treatment history, used by the physician to determine the patient s ventilator settings on day t. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 17/42
59 G-computation C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 18/42
60 G-computation Given the distribution of L 28 and the three assumptions above, the potential survivor function at day m (m 28) is identified via the following G-computation formula: C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 18/42
61 G-computation Given the distribution of L 28 and the three assumptions above, the potential survivor function at day m (m 28) is identified via the following G-computation formula: P[S m = 1] = P[Sm = 1 S 1 = 1, H 1 = h 1,U 0 = u 0 ]df(h 1 S 1 = 1,U 0 = u 0,H 0 = h 0 ) h 0 u 0 h 1 P[S 1 = 1 U 0 = u 0,H 0 = h 0 ]df(u 0 H 0 = h 0 )df(h 0 ) = P[Sm = 1 S 1 = 1,A 1 = 1, H 1 = h 1,U 0 = u 0 ] h 0 u 0 h 1 }{{} sequential randomization df(h 1 S 1 = 1,U 0 = u 0,H 0 = h 0 ) P[S 1 = 1 U 0 = u 0,H 0 = h 0 ]df(u 0 H 0 = h 0 )df(h 0 ) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 18/42
62 G-computation = P[Sm = 1 S 2 = 1,A 1 = 1, H 2 = h 2,Ū1 = ū 1 ] h 0 u 0 h 1 u 1 h 2 df(h 2 S 2 = 1,A 1 = 1, H 1 = h 1,Ū1 = ū 1 ) P[S 2 = 1 S 1 = 1,A 1 = 1, H 1 = h 1,Ū1 = ū 1 ] df(u 1 S 1 = 1,A 1 = 1, H 1 = h 1,U 0 = u 0 ) df(h 1 S 1 = 1,U 0 = u 0,H 0 = h 0 ) P[S 1 = 1 U 0 = u 0,H 0 = h 0 ]df(u 0 H 0 = h 0 )df(h 0 ) = P[Sm = 1 S 2 = 1,Ā2 = 1, H 2 = h 2,Ū1 = ū 1 ]... h 0 u 0 h 1 u 1 h 2 }{{} sequential randomization C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 19/42
63 G-computation. =... P[Sm = 1 S m 1 = 1,Ām 1 = 1, H m 1 = h m 1,Ūm 1 = ū m 1 ] h 0 u 0 h 1 u 1 h m 1 u m 1 m 1 t=1 { P[S t = 1 S t 1 = 1,Āt 1 = 1, H t 1 = h t 1,Ūt 1 = ū t 1 ] df(h t S t = 1,Āt 1 = 1, H t 1 = h t 1,Ūt 1 = ū t 1 ) } df(u t S t = 1,Āt = 1, H t = h t,ūt 1 = ū t 1 ) df(u 0 H 0 = h 0 )df(h 0 ) =... P[S m = 1 S m 1 = 1,Ām 1 = 1, H m 1 = h m 1,Ūm 1 = ū m 1 ] h 0 u 0 h 1 u 1 h m 1 u m 1 }{{} stochastic consistency... C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 20/42
64 Modeling of L 28 The likelihood of L 28 is as follows: Lik = df(h 0 )df(u 0 H 0 ) 28 t=1 { df(u t H t,ūt 1,S t = 1) df(h t H t 1,Ūt 1,S t = 1)} St df(st S t 1 = 1, H t 1,Ūt 1) S t 1. Additional Markovian Assumption Lik = df(h 0 )df(u 0 H 0 ) 28 t=1 { df(u t H t,u t 1,H 0,S t = 1) df(h t H t 1,U t 1,H 0,S t = 1)} StdF(St S t 1 = 1,H t 1,U t 1,H 0 ) S t 1. That is,a patient s status on day t only depends on his most recent history and the baseline H 0. C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 21/42
65 Models of S t df(s t S t 1 = 1,H t 1,U t 1,H 0 ) = df(s t S t 1 = 1,R t 1 = 1,G t 1,U t 1,H 0 ) Rt 1 df(s t S t 1 = 1,HSP t 1 = 1,ICU t 1 = 0,OF t 1,H 0 ) (1 Rt 1)(1 ICUt 1) ICUt 1(1 V NTt 1) df(s t S t 1 = 1,HSP t 1 = 1,ICU t 1 = 1,VNT t 1 = 0,OF t 1,H 0 ) for t = 1,...,28 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 22/42
66 Models of H t df(h t S t = 1,H t 1,U t 1,H 0 ) = df(hsp t S t = 1,HSP t 1 = 1,ICU t 1 = 0,OF t 1,H 0 ) HSPt 1(1 ICUt 1) df(icu t S t = 1,HSP t = 1,VNT t 1 = 0,OF t 1,H 0 ) HSPt(1 VNTt 1) df(vnt t S t = 1,HSP t = 1,ICU t = 1,R t 1 = 1,G t 1,U t 1,H 0 ) HSPtICUtRt 1 df(vnt t S t = 1,HSP t = 1,ICU t = 1,R t 1 = 0,OF t 1,H 0 ) HSPtICUt(1 Rt 1) df(lc t S t = 1,R t = 1,R t 1 = 1,G t 1,U t 1,H 0 ) RtRt 1 df(lc t S t = 1,R t = 1,R t 1 = 0,OF t 1,H 0 ) Rt(1 Rt 1) df(pe t S t = 1,R t = 1,R t 1 = 1,LC t,pe t 1,PD t 1,DS t 1,OF t 1,H 0 ) RtRt 1 df(pe t S t = 1,R t = 1,R t 1 = 0,LC t,of t 1,H 0 ) Rt(1 Rt 1) for t = 1,...,28 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 23/42
67 Models of U t df(ut St = 1,Ht,Ut 1,H0) = df(pht St = 1,Rt = 1,Rt 1 = 1,LCt,PHt 1,DSt 1,OFt 1,H0) RtRt 1 df(pht St = 1,Rt = 1,Rt 1 = 0,LCt,OFt 1,H0) Rt(1 Rt 1) df(pdt St = 1,Rt = 1,Rt 1 = 1,LCt,PEt,PDt 1,H0) RtRt 1 df(pdt St = 1,Rt = 1,Rt 1 = 0,LCt,PEt,OFt 1,H0) Rt(1 Rt 1) df(sot St = 1,Rt = 1,Rt 1 = 1,LCt,PEt,PHt,PDt,SOt 1,H0) RtRt 1 df(sot St = 1,Rt = 1,Rt 1 = 0,LCt,PEt,PHt,PDt,OFt 1,H0) Rt(1 Rt 1) df(srt St = 1,Rt = 1,Rt 1 = 1,LCt,PEt,PHt,SRt 1,DSt 1,OFt 1,H0) RtRt 1 df(srt St = 1,Rt = 1,Rt 1 = 0,LCt,PEt,PHt,OFt 1,H0) Rt(1 Rt 1) df(dst St = 1,Rt = 1,Rt 1 = 1,LCt,PEt,PHt,SOt,SRt,DSt 1,OFt 1,H0) RtRt 1 df(dst St = 1,Rt = 1,Rt 1 = 0,LCt,PEt,PHt,,SOt,SRt,OFt 1,H0) Rt(1 Rt 1) df(oft St = 1,Rt = 1,LCt,PEt,PHt,SOt,SRt,DSt,OFt 1,H0) Rt df(oft St = 1,Rt = 0,Rt 1 = 1,LCt 1,PEt 1,PHt 1,SOt 1,SRt 1,DSt 1,OFt 1,H0) (1 Rt)Rt 1 df(oft St = 1,HSPt = 1,VNTt = 0,Rt 1 = 0,ICUt 1 = 1,OFt 1,H0) HSPt(1 VNTt)(1 V NTt 1)ICUt 1 df(oft St = 1,HSPt = 1,VNTt = 0,HSPt 1 = 1,ICUt 1 = 0,OFt 1,H0) HSPt(1 VNTt)HSPt 1(1 ICUt 1) for t = 1,...,28 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 24/42
68 Monte Carlo Integration Algorithm C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 25/42
69 Monte Carlo Integration Algorithm (a) Set t = 0; sample AP, OF 0 ; set p 0 = 1 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 25/42
70 Monte Carlo Integration Algorithm (a) Set t = 0; sample AP, OF 0 ; set p 0 = 1 (b) Set t = t+1; set p t = p t 1 P[S t = 1 S t 1 = 1,H t 1,U t 1,H 0 ]. If t = 28, stop C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 25/42
71 Monte Carlo Integration Algorithm (a) Set t = 0; sample AP, OF 0 ; set p 0 = 1 (b) Set t = t+1; set p t = p t 1 P[S t = 1 S t 1 = 1,H t 1,U t 1,H 0 ]. If t = 28, stop (c) Sample HSP t, ICU t, VNT t, LC t C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 25/42
72 Monte Carlo Integration Algorithm (a) Set t = 0; sample AP, OF 0 ; set p 0 = 1 (b) Set t = t+1; set p t = p t 1 P[S t = 1 S t 1 = 1,H t 1,U t 1,H 0 ]. If t = 28, stop (c) Sample HSP t, ICU t, VNT t, LC t (d) Sample PE t, PH t, PD t, SO t, DS t C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 25/42
73 Monte Carlo Integration Algorithm (a) Set t = 0; sample AP, OF 0 ; set p 0 = 1 (b) Set t = t+1; set p t = p t 1 P[S t = 1 S t 1 = 1,H t 1,U t 1,H 0 ]. If t = 28, stop (c) Sample HSP t, ICU t, VNT t, LC t (d) Sample PE t, PH t, PD t, SO t, DS t (e) Set A t = I((VT t,sr t,ph t,pp t,ds t ) S). If A t = 0, go to (d) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 25/42
74 Monte Carlo Integration Algorithm (a) Set t = 0; sample AP, OF 0 ; set p 0 = 1 (b) Set t = t+1; set p t = p t 1 P[S t = 1 S t 1 = 1,H t 1,U t 1,H 0 ]. If t = 28, stop (c) Sample HSP t, ICU t, VNT t, LC t (d) Sample PE t, PH t, PD t, SO t, DS t (e) Set A t = I((VT t,sr t,ph t,pp t,ds t ) S). If A t = 0, go to (d) (f) Sample OF t ; go to (b) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 25/42
75 Outline 1 Acute Lung Injury and ARMA Trial 2 Bayesian Causal Inference 3 R and BUGS 4 Application Results of the ARMA Trial 5 Concluding Remarks C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 26/42
76 Flowchart Observed Data Data Manipulation in R R Calls BUGS BUGS Script Processed Data Initial Values Priors BUGS Model BUGS MCMC Sampling Posterior Samples N R Parallel G-computation Jobs N 4 R Summarization Results C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 27/42
77 The BUGS Project C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
78 The BUGS Project There are several versions of BUGS, which can be confusing C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
79 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
80 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
81 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
82 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable Can be extended. Add-ons: GeoBUGS, PKBUGS C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
83 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable Can be extended. Add-ons: GeoBUGS, PKBUGS Can be installed in Linux via wine and virtual screen server (e.g. Xvfb) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
84 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable Can be extended. Add-ons: GeoBUGS, PKBUGS Can be installed in Linux via wine and virtual screen server (e.g. Xvfb) OpenBUGS C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
85 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable Can be extended. Add-ons: GeoBUGS, PKBUGS Can be installed in Linux via wine and virtual screen server (e.g. Xvfb) OpenBUGS Latest version C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
86 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable Can be extended. Add-ons: GeoBUGS, PKBUGS Can be installed in Linux via wine and virtual screen server (e.g. Xvfb) OpenBUGS Latest version LinBUGS is the Linux based OpenBUGS C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
87 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable Can be extended. Add-ons: GeoBUGS, PKBUGS Can be installed in Linux via wine and virtual screen server (e.g. Xvfb) OpenBUGS Latest version LinBUGS is the Linux based OpenBUGS JAGS C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
88 The BUGS Project There are several versions of BUGS, which can be confusing WinBUGS Latest version Stand-alone and considered stable Can be extended. Add-ons: GeoBUGS, PKBUGS Can be installed in Linux via wine and virtual screen server (e.g. Xvfb) OpenBUGS Latest version LinBUGS is the Linux based OpenBUGS JAGS Just Another Gibbs Sampler, not part of the BUGS project C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 28/42
89 BUGS Script Example script.txt: modelcheck("model.txt") modeldata("data.txt") modelcompile() modelinits("inits.txt") modelupdate(10000) summaryset("a") samplesset("a") modelupdate(10000) summarystats("*") samplesstats("*") samplescoda("*","output") modelquit() C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 29/42
90 BUGS Model Example model.txt: model { for( i in 1 : N ) { mu[i] <- a+b*age[i] price[i] ~ dnorm(mu[i], tau) } tau ~ dgamma(0.001, 0.001) sigma <- 1 / sqrt(tau) a ~ dnorm(0, 1.0E-12) b ~ dnorm(0, 1.0E-12) } C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 30/42
91 BUGS Data Example init.txt: list(a=0, b=0, tau=1) Example data.txt: list(n=9, age = c(13, 14, 14,12, 9, 15, 10, 14, 9), price = c(295, 230, 390, 280, 500, 299, 390, 299, 450)) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 31/42
92 R Talks to BUGS C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
93 R Talks to BUGS R2WinBUGS, rbugs C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
94 R Talks to BUGS R2WinBUGS, rbugs Prepare files needed for running BUGS in batch-mode C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
95 R Talks to BUGS R2WinBUGS, rbugs Prepare files needed for running BUGS in batch-mode Running BUGS from R C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
96 R Talks to BUGS R2WinBUGS, rbugs Prepare files needed for running BUGS in batch-mode Running BUGS from R Save posterior samples for easy access in R C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
97 R Talks to BUGS R2WinBUGS, rbugs Prepare files needed for running BUGS in batch-mode Running BUGS from R Save posterior samples for easy access in R BRugs C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
98 R Talks to BUGS R2WinBUGS, rbugs Prepare files needed for running BUGS in batch-mode Running BUGS from R Save posterior samples for easy access in R BRugs Part of the OpenBUGS project C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
99 R Talks to BUGS R2WinBUGS, rbugs Prepare files needed for running BUGS in batch-mode Running BUGS from R Save posterior samples for easy access in R BRugs Part of the OpenBUGS project Instead of generating script file, capable of working interactively with BUGS C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
100 R Talks to BUGS R2WinBUGS, rbugs Prepare files needed for running BUGS in batch-mode Running BUGS from R Save posterior samples for easy access in R BRugs Part of the OpenBUGS project Instead of generating script file, capable of working interactively with BUGS Not for Linux. A new version may be out in one month or two to support Linux C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 32/42
101 Parallel Computing C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
102 Parallel Computing High-performance computing (HPC) uses supercomputers and computer clusters to solve advanced computation problems C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
103 Parallel Computing High-performance computing (HPC) uses supercomputers and computer clusters to solve advanced computation problems Parallel computing can be employed in HPC C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
104 Parallel Computing High-performance computing (HPC) uses supercomputers and computer clusters to solve advanced computation problems Parallel computing can be employed in HPC Embarrassingly parallel is one parallel computing case where no dependency exists between the parallel tasks C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
105 Parallel Computing High-performance computing (HPC) uses supercomputers and computer clusters to solve advanced computation problems Parallel computing can be employed in HPC Embarrassingly parallel is one parallel computing case where no dependency exists between the parallel tasks R Parallel Computing Frameworks C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
106 Parallel Computing High-performance computing (HPC) uses supercomputers and computer clusters to solve advanced computation problems Parallel computing can be employed in HPC Embarrassingly parallel is one parallel computing case where no dependency exists between the parallel tasks R Parallel Computing Frameworks Simple Network of Workstations (SNOW) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
107 Parallel Computing High-performance computing (HPC) uses supercomputers and computer clusters to solve advanced computation problems Parallel computing can be employed in HPC Embarrassingly parallel is one parallel computing case where no dependency exists between the parallel tasks R Parallel Computing Frameworks Simple Network of Workstations (SNOW) Simple Parallel R INTerface (SPRINT) C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
108 Parallel Computing High-performance computing (HPC) uses supercomputers and computer clusters to solve advanced computation problems Parallel computing can be employed in HPC Embarrassingly parallel is one parallel computing case where no dependency exists between the parallel tasks R Parallel Computing Frameworks Simple Network of Workstations (SNOW) Simple Parallel R INTerface (SPRINT) Rmpi C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 33/42
109 Example using Sun Grid Engine Shell Script qsub -N bugs qsub -N gcomp qsub -N rsum bugs.sh -hold_jid bugs -t gcomp.sh -hold_jid gcomp rsum.sh gcomp.sh R --vanilla --args $SGE_TASK_ID < GCOMP.R C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 34/42
110 Outline 1 Acute Lung Injury and ARMA Trial 2 Bayesian Causal Inference 3 R and BUGS 4 Application Results of the ARMA Trial 5 Concluding Remarks C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 35/42
111 Survival Rates Empirical (gray), posterior mean observed (dashed)) and potential (black) survival curves. Shaded area denote 95% posterior credible band for the potential survival curve: Survival Rate Observed Survival (Empirical) Observed Survival (Model Based) Potential Survival (Model Based) Days C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 36/42
112 Survival Rates Difference Posterior mean difference between observed and potential survival curves, with 95% posterior credible band: Difference Days C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 37/42
113 Outline 1 Acute Lung Injury and ARMA Trial 2 Bayesian Causal Inference 3 R and BUGS 4 Application Results of the ARMA Trial 5 Concluding Remarks C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 38/42
114 Summary C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 39/42
115 Summary We used the G-computation formula to estimate the potential survival distribution under the dynamic LTVV treatment regime for patients with acute lung injury C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 39/42
116 Summary We used the G-computation formula to estimate the potential survival distribution under the dynamic LTVV treatment regime for patients with acute lung injury Our results demonstrate that strict adherence to the LTVV algorithm does not lead to increased mortality C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 39/42
117 Summary We used the G-computation formula to estimate the potential survival distribution under the dynamic LTVV treatment regime for patients with acute lung injury Our results demonstrate that strict adherence to the LTVV algorithm does not lead to increased mortality The current methodology relies on untestable assumption that all the time-dependent confounders have been measured, i.e. no unmeasured confounding. Sensitivity of the conclusion to deviations from this assumption should be explored C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 39/42
118 Summary We used the G-computation formula to estimate the potential survival distribution under the dynamic LTVV treatment regime for patients with acute lung injury Our results demonstrate that strict adherence to the LTVV algorithm does not lead to increased mortality The current methodology relies on untestable assumption that all the time-dependent confounders have been measured, i.e. no unmeasured confounding. Sensitivity of the conclusion to deviations from this assumption should be explored We illustrated the utility of R and OpenBUGS for the Bayesian implementation of the proposed methodology C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 39/42
119 Summary We used the G-computation formula to estimate the potential survival distribution under the dynamic LTVV treatment regime for patients with acute lung injury Our results demonstrate that strict adherence to the LTVV algorithm does not lead to increased mortality The current methodology relies on untestable assumption that all the time-dependent confounders have been measured, i.e. no unmeasured confounding. Sensitivity of the conclusion to deviations from this assumption should be explored We illustrated the utility of R and OpenBUGS for the Bayesian implementation of the proposed methodology With the dissemination and popularization of High Performance Computing, parallel computation will become mainstream for all scientific researchers including statisticians C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 39/42
120 THE END C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 40/42
121 BLANK C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 41/42
122 Tips for R Installation C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
123 Tips for R Installation R version has been released on 05/31/2010 C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
124 Tips for R Installation R version has been released on 05/31/2010 Use./configure -prefix= to specify the destination folder for installation C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
125 Tips for R Installation R version has been released on 05/31/2010 Use./configure -prefix= to specify the destination folder for installation Use export R_LIBS= to set up the local R package library path C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
126 Tips for R Installation R version has been released on 05/31/2010 Use./configure -prefix= to specify the destination folder for installation Use export R_LIBS= to set up the local R package library path To install R2WinBUGS in the latest version R, packages lattice and coda need to be installed separately C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
127 Tips for R Installation R version has been released on 05/31/2010 Use./configure -prefix= to specify the destination folder for installation Use export R_LIBS= to set up the local R package library path To install R2WinBUGS in the latest version R, packages lattice and coda need to be installed separately Set export BUGS= for rbugs C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
128 Tips for R Installation R version has been released on 05/31/2010 Use./configure -prefix= to specify the destination folder for installation Use export R_LIBS= to set up the local R package library path To install R2WinBUGS in the latest version R, packages lattice and coda need to be installed separately Set export BUGS= for rbugs Extensions C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
129 Tips for R Installation R version has been released on 05/31/2010 Use./configure -prefix= to specify the destination folder for installation Use export R_LIBS= to set up the local R package library path To install R2WinBUGS in the latest version R, packages lattice and coda need to be installed separately Set export BUGS= for rbugs Extensions Use Rprof and summaryrprof to find the computation bottleneck C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
130 Tips for R Installation R version has been released on 05/31/2010 Use./configure -prefix= to specify the destination folder for installation Use export R_LIBS= to set up the local R package library path To install R2WinBUGS in the latest version R, packages lattice and coda need to be installed separately Set export BUGS= for rbugs Extensions Use Rprof and summaryrprof to find the computation bottleneck Use C or Fortran extensions to expedite the computation C. Wang, D.O. Scharfstein, M.J. Daniels Evaluate the Causal Effect of DTR 42/42
Advanced Statistical Modelling
Markov chain Monte Carlo (MCMC) Methods and Their Applications in Bayesian Statistics School of Technology and Business Studies/Statistics Dalarna University Borlänge, Sweden. Feb. 05, 2014. Outlines 1
More informationRobust Bayesian Regression
Readings: Hoff Chapter 9, West JRSSB 1984, Fúquene, Pérez & Pericchi 2015 Duke University November 17, 2016 Body Fat Data: Intervals w/ All Data Response % Body Fat and Predictor Waist Circumference 95%
More informationIntroduction to Bayesian Statistics and Markov Chain Monte Carlo Estimation. EPSY 905: Multivariate Analysis Spring 2016 Lecture #10: April 6, 2016
Introduction to Bayesian Statistics and Markov Chain Monte Carlo Estimation EPSY 905: Multivariate Analysis Spring 2016 Lecture #10: April 6, 2016 EPSY 905: Intro to Bayesian and MCMC Today s Class An
More informationWinBUGS : part 2. Bruno Boulanger Jonathan Jaeger Astrid Jullion Philippe Lambert. Gabriele, living with rheumatoid arthritis
WinBUGS : part 2 Bruno Boulanger Jonathan Jaeger Astrid Jullion Philippe Lambert Gabriele, living with rheumatoid arthritis Agenda 2! Hierarchical model: linear regression example! R2WinBUGS Linear Regression
More informationPrerequisite: STATS 7 or STATS 8 or AP90 or (STATS 120A and STATS 120B and STATS 120C). AP90 with a minimum score of 3
University of California, Irvine 2017-2018 1 Statistics (STATS) Courses STATS 5. Seminar in Data Science. 1 Unit. An introduction to the field of Data Science; intended for entering freshman and transfers.
More informationMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Harvard-MIT Division of Health Sciences and Technology HST.54J: Quantitative Physiology: Organ Transport Systems Instructors: Roger Mark and Jose Venegas MASSACHUSETTS INSTITUTE OF TECHNOLOGY Departments
More informationUsing Post Outcome Measurement Information in Censoring by Death Problems
Using Post Outcome Measurement Information in Censoring by Death Problems Fan Yang University of Chicago, Chicago, USA. Dylan S. Small University of Pennsylvania, Philadelphia, USA. Summary. Many clinical
More informationTargeted Maximum Likelihood Estimation in Safety Analysis
Targeted Maximum Likelihood Estimation in Safety Analysis Sam Lendle 1 Bruce Fireman 2 Mark van der Laan 1 1 UC Berkeley 2 Kaiser Permanente ISPE Advanced Topics Session, Barcelona, August 2012 1 / 35
More informationBayesian Statistics Comparing Two Proportions or Means
Bayesian Statistics Comparing Two Proportions or Means Michael Anderson, PhD Hélène Carabin, DVM, PhD Department of Biostatistics and Epidemiology The University of Oklahoma Health Sciences Center May
More informationA multi-state model for the prognosis of non-mild acute pancreatitis
A multi-state model for the prognosis of non-mild acute pancreatitis Lore Zumeta Olaskoaga 1, Felix Zubia Olaskoaga 2, Guadalupe Gómez Melis 1 1 Universitat Politècnica de Catalunya 2 Intensive Care Unit,
More informationThe STS Surgeon Composite Technical Appendix
The STS Surgeon Composite Technical Appendix Overview Surgeon-specific risk-adjusted operative operative mortality and major complication rates were estimated using a bivariate random-effects logistic
More informationCausal Hazard Ratio Estimation By Instrumental Variables or Principal Stratification. Todd MacKenzie, PhD
Causal Hazard Ratio Estimation By Instrumental Variables or Principal Stratification Todd MacKenzie, PhD Collaborators A. James O Malley Tor Tosteson Therese Stukel 2 Overview 1. Instrumental variable
More informationCase Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial
Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial William R. Gillespie Pharsight Corporation Cary, North Carolina, USA PAGE 2003 Verona,
More informationA Bayesian Nonparametric Approach to Monotone Missing Data in Longitudinal Studies with Informative Missingness
A Bayesian Nonparametric Approach to Monotone Missing Data in Longitudinal Studies with Informative Missingness A. Linero and M. Daniels UF, UT-Austin SRC 2014, Galveston, TX 1 Background 2 Working model
More informationBayesian Graphical Models
Graphical Models and Inference, Lecture 16, Michaelmas Term 2009 December 4, 2009 Parameter θ, data X = x, likelihood L(θ x) p(x θ). Express knowledge about θ through prior distribution π on θ. Inference
More informationA Bayesian Nonparametric Approach to Causal Inference for Semi-competing risks
A Bayesian Nonparametric Approach to Causal Inference for Semi-competing risks Y. Xu, D. Scharfstein, P. Mueller, M. Daniels Johns Hopkins, Johns Hopkins, UT-Austin, UF JSM 2018, Vancouver 1 What are semi-competing
More informationCausal Inference Basics
Causal Inference Basics Sam Lendle October 09, 2013 Observed data, question, counterfactuals Observed data: n i.i.d copies of baseline covariates W, treatment A {0, 1}, and outcome Y. O i = (W i, A i,
More informationInterim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming. and Optimal Stopping
Interim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj
More informationEstimating Causal Effects of Organ Transplantation Treatment Regimes
Estimating Causal Effects of Organ Transplantation Treatment Regimes David M. Vock, Jeffrey A. Verdoliva Boatman Division of Biostatistics University of Minnesota July 31, 2018 1 / 27 Hot off the Press
More informationDIC: Deviance Information Criterion
(((( Welcome Page Latest News DIC: Deviance Information Criterion Contact us/bugs list WinBUGS New WinBUGS examples FAQs DIC GeoBUGS DIC (Deviance Information Criterion) is a Bayesian method for model
More informationEstimating the Mean Response of Treatment Duration Regimes in an Observational Study. Anastasios A. Tsiatis.
Estimating the Mean Response of Treatment Duration Regimes in an Observational Study Anastasios A. Tsiatis http://www.stat.ncsu.edu/ tsiatis/ Introduction to Dynamic Treatment Regimes 1 Outline Description
More informationA multi-state model for the prognosis of non-mild acute pancreatitis
A multi-state model for the prognosis of non-mild acute pancreatitis Lore Zumeta Olaskoaga 1, Felix Zubia Olaskoaga 2, Marta Bofill Roig 1, Guadalupe Gómez Melis 1 1 Universitat Politècnica de Catalunya
More informationBayesian philosophy Bayesian computation Bayesian software. Bayesian Statistics. Petter Mostad. Chalmers. April 6, 2017
Chalmers April 6, 2017 Bayesian philosophy Bayesian philosophy Bayesian statistics versus classical statistics: War or co-existence? Classical statistics: Models have variables and parameters; these are
More informationCausal Inference. Miguel A. Hernán, James M. Robins. May 19, 2017
Causal Inference Miguel A. Hernán, James M. Robins May 19, 2017 ii Causal Inference Part III Causal inference from complex longitudinal data Chapter 19 TIME-VARYING TREATMENTS So far this book has dealt
More informationOptimising Group Sequential Designs. Decision Theory, Dynamic Programming. and Optimal Stopping
: Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj InSPiRe Conference on Methodology
More informationBUGS Bayesian inference Using Gibbs Sampling
BUGS Bayesian inference Using Gibbs Sampling Glen DePalma Department of Statistics May 30, 2013 www.stat.purdue.edu/~gdepalma 1 / 20 Bayesian Philosophy I [Pearl] turned Bayesian in 1971, as soon as I
More informationIndividualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models
Individualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models Nicholas C. Henderson Thomas A. Louis Gary Rosner Ravi Varadhan Johns Hopkins University July 31, 2018
More informationAdaptive Prediction of Event Times in Clinical Trials
Adaptive Prediction of Event Times in Clinical Trials Yu Lan Southern Methodist University Advisor: Daniel F. Heitjan May 8, 2017 Yu Lan (SMU) May 8, 2017 1 / 19 Clinical Trial Prediction Event-based trials:
More informationProbabilistic Machine Learning
Probabilistic Machine Learning Bayesian Nets, MCMC, and more Marek Petrik 4/18/2017 Based on: P. Murphy, K. (2012). Machine Learning: A Probabilistic Perspective. Chapter 10. Conditional Independence Independent
More informationMarginal versus conditional effects: does it make a difference? Mireille Schnitzer, PhD Université de Montréal
Marginal versus conditional effects: does it make a difference? Mireille Schnitzer, PhD Université de Montréal Overview In observational and experimental studies, the goal may be to estimate the effect
More informationDAG models and Markov Chain Monte Carlo methods a short overview
DAG models and Markov Chain Monte Carlo methods a short overview Søren Højsgaard Institute of Genetics and Biotechnology University of Aarhus August 18, 2008 Printed: August 18, 2008 File: DAGMC-Lecture.tex
More informationA Sampling of IMPACT Research:
A Sampling of IMPACT Research: Methods for Analysis with Dropout and Identifying Optimal Treatment Regimes Marie Davidian Department of Statistics North Carolina State University http://www.stat.ncsu.edu/
More informationCausal Sensitivity Analysis for Decision Trees
Causal Sensitivity Analysis for Decision Trees by Chengbo Li A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Master of Mathematics in Computer
More informationBayesian Inference and MCMC
Bayesian Inference and MCMC Aryan Arbabi Partly based on MCMC slides from CSC412 Fall 2018 1 / 18 Bayesian Inference - Motivation Consider we have a data set D = {x 1,..., x n }. E.g each x i can be the
More informationFast Likelihood-Free Inference via Bayesian Optimization
Fast Likelihood-Free Inference via Bayesian Optimization Michael Gutmann https://sites.google.com/site/michaelgutmann University of Helsinki Aalto University Helsinki Institute for Information Technology
More informationR Demonstration ANCOVA
R Demonstration ANCOVA Objective: The purpose of this week s session is to demonstrate how to perform an analysis of covariance (ANCOVA) in R, and how to plot the regression lines for each level of the
More informationIntroduction to Statistical Inference
Introduction to Statistical Inference Kosuke Imai Princeton University January 31, 2010 Kosuke Imai (Princeton) Introduction to Statistical Inference January 31, 2010 1 / 21 What is Statistics? Statistics
More informationEstimating Optimal Dynamic Treatment Regimes from Clustered Data
Estimating Optimal Dynamic Treatment Regimes from Clustered Data Bibhas Chakraborty Department of Biostatistics, Columbia University bc2425@columbia.edu Society for Clinical Trials Annual Meetings Boston,
More information2 Describing Contingency Tables
2 Describing Contingency Tables I. Probability structure of a 2-way contingency table I.1 Contingency Tables X, Y : cat. var. Y usually random (except in a case-control study), response; X can be random
More informationWhy Bayesian approaches? The average height of a rare plant
Why Bayesian approaches? The average height of a rare plant Estimation and comparison of averages is an important step in many ecological analyses and demographic models. In this demonstration you will
More information(5) Multi-parameter models - Gibbs sampling. ST440/540: Applied Bayesian Analysis
Summarizing a posterior Given the data and prior the posterior is determined Summarizing the posterior gives parameter estimates, intervals, and hypothesis tests Most of these computations are integrals
More informationA Tutorial on Learning with Bayesian Networks
A utorial on Learning with Bayesian Networks David Heckerman Presented by: Krishna V Chengavalli April 21 2003 Outline Introduction Different Approaches Bayesian Networks Learning Probabilities and Structure
More informationCausal Inference with Big Data Sets
Causal Inference with Big Data Sets Marcelo Coca Perraillon University of Colorado AMC November 2016 1 / 1 Outlone Outline Big data Causal inference in economics and statistics Regression discontinuity
More informationBayesian Inference on Joint Mixture Models for Survival-Longitudinal Data with Multiple Features. Yangxin Huang
Bayesian Inference on Joint Mixture Models for Survival-Longitudinal Data with Multiple Features Yangxin Huang Department of Epidemiology and Biostatistics, COPH, USF, Tampa, FL yhuang@health.usf.edu January
More informationCausal Modeling in Environmental Epidemiology. Joel Schwartz Harvard University
Causal Modeling in Environmental Epidemiology Joel Schwartz Harvard University When I was Young What do I mean by Causal Modeling? What would have happened if the population had been exposed to a instead
More informationComparative effectiveness of dynamic treatment regimes
Comparative effectiveness of dynamic treatment regimes An application of the parametric g- formula Miguel Hernán Departments of Epidemiology and Biostatistics Harvard School of Public Health www.hsph.harvard.edu/causal
More informationMultistate models and recurrent event models
Multistate models Multistate models and recurrent event models Patrick Breheny December 10 Patrick Breheny Survival Data Analysis (BIOS 7210) 1/22 Introduction Multistate models In this final lecture,
More informationMixture modelling of recurrent event times with long-term survivors: Analysis of Hutterite birth intervals. John W. Mac McDonald & Alessandro Rosina
Mixture modelling of recurrent event times with long-term survivors: Analysis of Hutterite birth intervals John W. Mac McDonald & Alessandro Rosina Quantitative Methods in the Social Sciences Seminar -
More informationSample Size Determination
Sample Size Determination 018 The number of subjects in a clinical study should always be large enough to provide a reliable answer to the question(s addressed. The sample size is usually determined by
More informationWhether to use MMRM as primary estimand.
Whether to use MMRM as primary estimand. James Roger London School of Hygiene & Tropical Medicine, London. PSI/EFSPI European Statistical Meeting on Estimands. Stevenage, UK: 28 September 2015. 1 / 38
More informationANALYTIC COMPARISON. Pearl and Rubin CAUSAL FRAMEWORKS
ANALYTIC COMPARISON of Pearl and Rubin CAUSAL FRAMEWORKS Content Page Part I. General Considerations Chapter 1. What is the question? 16 Introduction 16 1. Randomization 17 1.1 An Example of Randomization
More informationGroup Sequential Designs: Theory, Computation and Optimisation
Group Sequential Designs: Theory, Computation and Optimisation Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj 8th International Conference
More informationBayesian Networks Inference with Probabilistic Graphical Models
4190.408 2016-Spring Bayesian Networks Inference with Probabilistic Graphical Models Byoung-Tak Zhang intelligence Lab Seoul National University 4190.408 Artificial (2016-Spring) 1 Machine Learning? Learning
More informationAnalysis of Longitudinal Data. Patrick J. Heagerty PhD Department of Biostatistics University of Washington
Analysis of Longitudinal Data Patrick J Heagerty PhD Department of Biostatistics University of Washington Auckland 8 Session One Outline Examples of longitudinal data Scientific motivation Opportunities
More informationA Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes Thomas A. Murray, (tamurray@mdanderson.org), Ying Yuan, (yyuan@mdanderson.org), and Peter F. Thall (rex@mdanderson.org) Department
More informationAnalysing longitudinal data when the visit times are informative
Analysing longitudinal data when the visit times are informative Eleanor Pullenayegum, PhD Scientist, Hospital for Sick Children Associate Professor, University of Toronto eleanor.pullenayegum@sickkids.ca
More informationLecture 13 Fundamentals of Bayesian Inference
Lecture 13 Fundamentals of Bayesian Inference Dennis Sun Stats 253 August 11, 2014 Outline of Lecture 1 Bayesian Models 2 Modeling Correlations Using Bayes 3 The Universal Algorithm 4 BUGS 5 Wrapping Up
More informationCausality II: How does causal inference fit into public health and what it is the role of statistics?
Causality II: How does causal inference fit into public health and what it is the role of statistics? Statistics for Psychosocial Research II November 13, 2006 1 Outline Potential Outcomes / Counterfactual
More informationApproximation of Survival Function by Taylor Series for General Partly Interval Censored Data
Malaysian Journal of Mathematical Sciences 11(3): 33 315 (217) MALAYSIAN JOURNAL OF MATHEMATICAL SCIENCES Journal homepage: http://einspem.upm.edu.my/journal Approximation of Survival Function by Taylor
More informationIncorporating cost in Bayesian variable selection, with application to cost-effective measurement of quality of health care
Incorporating cost in Bayesian variable selection, with application to cost-effective measurement of quality of health care Dimitris Fouskakis, Department of Mathematics, School of Applied Mathematical
More informationEstimation of Optimal Treatment Regimes Via Machine Learning. Marie Davidian
Estimation of Optimal Treatment Regimes Via Machine Learning Marie Davidian Department of Statistics North Carolina State University Triangle Machine Learning Day April 3, 2018 1/28 Optimal DTRs Via ML
More informationDeep Temporal Generative Models of. Rahul Krishnan, Uri Shalit, David Sontag
Deep Temporal Generative Models of Rahul Krishnan, Uri Shalit, David Sontag Patient timeline Jan 1 Feb 12 May 15 Blood pressure = 130 WBC count = 6*10 9 /L Temperature = 98 F A1c = 6.6% Precancerous cells
More informationMarkov Chain Monte Carlo
Markov Chain Monte Carlo Jamie Monogan University of Georgia Spring 2013 For more information, including R programs, properties of Markov chains, and Metropolis-Hastings, please see: http://monogan.myweb.uga.edu/teaching/statcomp/mcmc.pdf
More informationMcGill University. Department of Epidemiology and Biostatistics. Bayesian Analysis for the Health Sciences. Course EPIB-675.
McGill University Department of Epidemiology and Biostatistics Bayesian Analysis for the Health Sciences Course EPIB-675 Lawrence Joseph Bayesian Analysis for the Health Sciences EPIB-675 3 credits Instructor:
More informationPotential Outcomes and Causal Inference I
Potential Outcomes and Causal Inference I Jonathan Wand Polisci 350C Stanford University May 3, 2006 Example A: Get-out-the-Vote (GOTV) Question: Is it possible to increase the likelihood of an individuals
More informationSpatial discrete hazards using Hierarchical Bayesian Modeling
Spatial discrete hazards using Hierarchical Bayesian Modeling Mathias Graf ETH Zurich, Institute for Structural Engineering, Group Risk & Safety 1 Papers -Maes, M.A., Dann M., Sarkar S., and Midtgaard,
More informationStatistical models for estimating the effects of intermediate variables in the presence of time-dependent confounders
Statistical models for estimating the effects of intermediate variables in the presence of time-dependent confounders Dissertation zur Erlangung des Dotorgrades der Faultät für Mathemati und Physi der
More informationThe lmm Package. May 9, Description Some improved procedures for linear mixed models
The lmm Package May 9, 2005 Version 0.3-4 Date 2005-5-9 Title Linear mixed models Author Original by Joseph L. Schafer . Maintainer Jing hua Zhao Description Some improved
More informationMultistate models and recurrent event models
and recurrent event models Patrick Breheny December 6 Patrick Breheny University of Iowa Survival Data Analysis (BIOS:7210) 1 / 22 Introduction In this final lecture, we will briefly look at two other
More informationSEQUENTIAL MULTIPLE ASSIGNMENT RANDOMIZATION TRIALS WITH ENRICHMENT (SMARTER) DESIGN
SEQUENTIAL MULTIPLE ASSIGNMENT RANDOMIZATION TRIALS WITH ENRICHMENT (SMARTER) DESIGN Ying Liu Division of Biostatistics, Medical College of Wisconsin Yuanjia Wang Department of Biostatistics & Psychiatry,
More informationMetric Predicted Variable on One Group
Metric Predicted Variable on One Group Tim Frasier Copyright Tim Frasier This work is licensed under the Creative Commons Attribution 4.0 International license. Click here for more information. Prior Homework
More informationBayesian Networks in Educational Assessment
Bayesian Networks in Educational Assessment Estimating Parameters with MCMC Bayesian Inference: Expanding Our Context Roy Levy Arizona State University Roy.Levy@asu.edu 2017 Roy Levy MCMC 1 MCMC 2 Posterior
More information36-463/663Multilevel and Hierarchical Models
36-463/663Multilevel and Hierarchical Models From Bayes to MCMC to MLMs Brian Junker 132E Baker Hall brian@stat.cmu.edu 1 Outline Bayesian Statistics and MCMC Distribution of Skill Mastery in a Population
More informationPackage lmm. R topics documented: March 19, Version 0.4. Date Title Linear mixed models. Author Joseph L. Schafer
Package lmm March 19, 2012 Version 0.4 Date 2012-3-19 Title Linear mixed models Author Joseph L. Schafer Maintainer Jing hua Zhao Depends R (>= 2.0.0) Description Some
More informationJanuary NCCTG Protocol No: N0927 Opened: September 3, 2009
January 2011 0915-1 RTOG Protocol No: 0915 Protocol Status: NCCTG Protocol No: N0927 Opened: September 3, 2009 Title: A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT)
More informationFAV i R This paper is produced mechanically as part of FAViR. See for more information.
Bayesian Claim Severity Part 2 Mixed Exponentials with Trend, Censoring, and Truncation By Benedict Escoto FAV i R This paper is produced mechanically as part of FAViR. See http://www.favir.net for more
More informationCausal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules
University of California, Berkeley From the SelectedWorks of Maya Petersen March, 2007 Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules Mark J van der Laan, University
More informationOptimal Patient-specific Post-operative Surveillance for Vascular Surgeries
Optimal Patient-specific Post-operative Surveillance for Vascular Surgeries Peter I. Frazier, Shanshan Zhang, Pranav Hanagal School of Operations Research & Information Engineering, Cornell University
More informationLecture 7 Time-dependent Covariates in Cox Regression
Lecture 7 Time-dependent Covariates in Cox Regression So far, we ve been considering the following Cox PH model: λ(t Z) = λ 0 (t) exp(β Z) = λ 0 (t) exp( β j Z j ) where β j is the parameter for the the
More informationDiscussion on Fygenson (2007, Statistica Sinica): a DS Perspective
1 Discussion on Fygenson (2007, Statistica Sinica): a DS Perspective Chuanhai Liu Purdue University 1. Introduction In statistical analysis, it is important to discuss both uncertainty due to model choice
More informationTargeted Learning for High-Dimensional Variable Importance
Targeted Learning for High-Dimensional Variable Importance Alan Hubbard, Nima Hejazi, Wilson Cai, Anna Decker Division of Biostatistics University of California, Berkeley July 27, 2016 for Centre de Recherches
More informationBayesian Meta-analysis with Hierarchical Modeling Brian P. Hobbs 1
Bayesian Meta-analysis with Hierarchical Modeling Brian P. Hobbs 1 Division of Biostatistics, School of Public Health, University of Minnesota, Mayo Mail Code 303, Minneapolis, Minnesota 55455 0392, U.S.A.
More informationBayesian Inference for Regression Parameters
Bayesian Inference for Regression Parameters 1 Bayesian inference for simple linear regression parameters follows the usual pattern for all Bayesian analyses: 1. Form a prior distribution over all unknown
More informationModelling geoadditive survival data
Modelling geoadditive survival data Thomas Kneib & Ludwig Fahrmeir Department of Statistics, Ludwig-Maximilians-University Munich 1. Leukemia survival data 2. Structured hazard regression 3. Mixed model
More informationInstrumental variables estimation in the Cox Proportional Hazard regression model
Instrumental variables estimation in the Cox Proportional Hazard regression model James O Malley, Ph.D. Department of Biomedical Data Science The Dartmouth Institute for Health Policy and Clinical Practice
More informationTreatment Effects. Christopher Taber. September 6, Department of Economics University of Wisconsin-Madison
Treatment Effects Christopher Taber Department of Economics University of Wisconsin-Madison September 6, 2017 Notation First a word on notation I like to use i subscripts on random variables to be clear
More informationBayesian Estimation of the Time of a Linear Trend in Risk-Adjusted Control Charts
Bayesian Estimation of the Time of a Linear Trend in Risk-Adjusted Control Charts Hassan Assareh, Ian Smith, Kerrie Mengersen Abstract Change point detection is recognized as an essential tool of root
More informationLecture 1 January 18
STAT 263/363: Experimental Design Winter 2016/17 Lecture 1 January 18 Lecturer: Art B. Owen Scribe: Julie Zhu Overview Experiments are powerful because you can conclude causality from the results. In most
More informationAn Introduction to WinBUGS PIMS Collaborative Research Group Summer School on Bayesian Modeling and Computation
An Introduction to PIMS Collaborative Research Group Summer School on Bayesian Modeling and Computation 14 th July, 2008 Sebastien Haneuse, PhD Group Health Center for Health Studies Department of Biostatistics,
More informationBayesian regression tree models for causal inference: regularization, confounding and heterogeneity
Bayesian regression tree models for causal inference: regularization, confounding and heterogeneity P. Richard Hahn, Jared Murray, and Carlos Carvalho June 22, 2017 The problem setting We want to estimate
More informationBNP survival regression with variable dimension covariate vector
BNP survival regression with variable dimension covariate vector Peter Müller, UT Austin Survival 0.0 0.2 0.4 0.6 0.8 1.0 Truth Estimate Survival 0.0 0.2 0.4 0.6 0.8 1.0 Truth Estimate BC, BRAF TT (left),
More informationChapter 11. Correlation and Regression
Chapter 11. Correlation and Regression The word correlation is used in everyday life to denote some form of association. We might say that we have noticed a correlation between foggy days and attacks of
More informationMcGill University. Department of Epidemiology and Biostatistics. Bayesian Analysis for the Health Sciences. Course EPIB-682.
McGill University Department of Epidemiology and Biostatistics Bayesian Analysis for the Health Sciences Course EPIB-682 Lawrence Joseph Intro to Bayesian Analysis for the Health Sciences EPIB-682 2 credits
More informationBayesian inference. Fredrik Ronquist and Peter Beerli. October 3, 2007
Bayesian inference Fredrik Ronquist and Peter Beerli October 3, 2007 1 Introduction The last few decades has seen a growing interest in Bayesian inference, an alternative approach to statistical inference.
More informationMeasuring Social Influence Without Bias
Measuring Social Influence Without Bias Annie Franco Bobbie NJ Macdonald December 9, 2015 The Problem CS224W: Final Paper How well can statistical models disentangle the effects of social influence from
More informationMetric Predicted Variable With One Nominal Predictor Variable
Metric Predicted Variable With One Nominal Predictor Variable Tim Frasier Copyright Tim Frasier This work is licensed under the Creative Commons Attribution 4.0 International license. Click here for more
More informationCluster Analysis using SaTScan
Cluster Analysis using SaTScan Summary 1. Statistical methods for spatial epidemiology 2. Cluster Detection What is a cluster? Few issues 3. Spatial and spatio-temporal Scan Statistic Methods Probability
More informationarxiv: v5 [stat.me] 13 Feb 2018
arxiv: arxiv:1602.07933 BOOTSTRAP INFERENCE WHEN USING MULTIPLE IMPUTATION By Michael Schomaker and Christian Heumann University of Cape Town and Ludwig-Maximilians Universität München arxiv:1602.07933v5
More informationMultivariate Survival Analysis
Multivariate Survival Analysis Previously we have assumed that either (X i, δ i ) or (X i, δ i, Z i ), i = 1,..., n, are i.i.d.. This may not always be the case. Multivariate survival data can arise in
More informationLectures of STA 231: Biostatistics
Lectures of STA 231: Biostatistics Second Semester Academic Year 2016/2017 Text Book Biostatistics: Basic Concepts and Methodology for the Health Sciences (10 th Edition, 2014) By Wayne W. Daniel Prepared
More information